ATE242638T1 - Verwendung einer zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen zur vorbeugung und/oder behandlung von lungenerkrankungen - Google Patents

Verwendung einer zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen zur vorbeugung und/oder behandlung von lungenerkrankungen

Info

Publication number
ATE242638T1
ATE242638T1 AT99972540T AT99972540T ATE242638T1 AT E242638 T1 ATE242638 T1 AT E242638T1 AT 99972540 T AT99972540 T AT 99972540T AT 99972540 T AT99972540 T AT 99972540T AT E242638 T1 ATE242638 T1 AT E242638T1
Authority
AT
Austria
Prior art keywords
soy protein
composition
dietary fibers
phytoestrogen
prevention
Prior art date
Application number
AT99972540T
Other languages
English (en)
Inventor
Lars Henrik Hoie
Original Assignee
Nutri Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutri Pharma As filed Critical Nutri Pharma As
Application granted granted Critical
Publication of ATE242638T1 publication Critical patent/ATE242638T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Botany (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT99972540T 1998-11-25 1999-11-25 Verwendung einer zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen zur vorbeugung und/oder behandlung von lungenerkrankungen ATE242638T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199801557 1998-11-25
PCT/IB1999/001997 WO2000030664A1 (en) 1998-11-25 1999-11-25 Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of pulmonary diseases

Publications (1)

Publication Number Publication Date
ATE242638T1 true ATE242638T1 (de) 2003-06-15

Family

ID=8106042

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99972540T ATE242638T1 (de) 1998-11-25 1999-11-25 Verwendung einer zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen zur vorbeugung und/oder behandlung von lungenerkrankungen

Country Status (10)

Country Link
US (1) US6509043B1 (de)
EP (1) EP1133307B1 (de)
JP (1) JP2002530346A (de)
AT (1) ATE242638T1 (de)
AU (1) AU1404600A (de)
BR (1) BR9915689A (de)
CA (1) CA2352338A1 (de)
DE (1) DE69908809D1 (de)
HK (1) HK1041634A1 (de)
WO (1) WO2000030664A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU767245B2 (en) * 1998-11-25 2003-11-06 Nutri Pharma Asa Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases
US6733815B2 (en) 1999-04-16 2004-05-11 Cargill, Incorporated Food ingredient containing wheat gluten, soy grits and soy flour
US6592910B1 (en) 1999-04-20 2003-07-15 Board Of Trustees, Southern Illinois University Methods of treating clinical diseases with isoflavones
KR20030005280A (ko) 2000-04-14 2003-01-17 마아즈, 인코오포레이티드 혈관의 건강을 개선하기 위한 조성물과 방법
US6559177B2 (en) 2001-04-19 2003-05-06 Wyeth 5, 11-Dioxa-benzo[b]fluoren-10-one and 5-oxa-11-thia-benzo[b]fluoren-10-ones as estrogenic agents
US6589980B2 (en) 2001-05-17 2003-07-08 Wyeth Substituted 10,11-benzo[b]fluoren-10-ones as estrogenic agents
EP1443946A2 (de) * 2001-07-03 2004-08-11 Nutri Pharma ASA Soja-enthaltende zusammensetzung und deren verwendung zur prävention und/oder behandlung von verschiedenen krankheiten
AU2003206050A1 (en) * 2002-02-22 2003-09-09 Nutri Pharma Asa Food products comprising soy protein
EP1480525A2 (de) * 2002-02-23 2004-12-01 Nutri Pharma ASA Neue sojaproteinprodukte
US8668914B2 (en) * 2002-07-24 2014-03-11 Brigham Young University Use of equol for treating skin diseases
AU2003259220C1 (en) 2002-07-24 2017-08-24 Australian Health & Nutrition Association Limited Compositions and products containing enantiomeric equol, and methods for their making
EP1569636B1 (de) * 2002-10-29 2017-12-13 Colorado State University Research Foundation Verwendung von equol zur behandlung von androgenvermittelten erkrankungen
US8580846B2 (en) 2002-10-29 2013-11-12 Brigham Young University Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders
WO2005048929A2 (en) * 2003-11-13 2005-06-02 Galileo Pharmaceuticals, Inc. Plant-derived protein extract compositions and methods
CA2564399A1 (en) * 2004-04-28 2005-11-17 Brigham Young University Use of equol for treating skin diseases
US20050261197A1 (en) * 2004-05-19 2005-11-24 Henry Aoki Coffee bean extract, method of extraction and composition containing the same
US20060280840A1 (en) * 2005-05-24 2006-12-14 Robertson Marion G Universal protein formulation meeting multiple dietary needs for optimal health and enhancing the human immune system
WO2014145086A2 (en) 2013-03-15 2014-09-18 Galvez Alfredo Flores Products and methods using lunasin-enriched soy extract mixtures to reduce free fatty acid levels, increase leptin levels and increase adiponectin levels in plasma
CN105658079A (zh) * 2013-10-11 2016-06-08 U·拉贾卡鲁纳 食品添加剂及其制造和使用方法
WO2021064107A1 (en) 2019-10-02 2021-04-08 Norvia Nutrition Ltd. Composition comprising soy and use thereof in the prevention and/or treatment of microvascular or lipoprotein related diseases, microcardiovascular diseases, atherosclerosis, hypertension, and in patients with such cardiovascular disorders suffering from alzheimer and dementia, overweight and obesity, type 2 diabetes, asthma and other disorders
JP2023088736A (ja) * 2021-12-15 2023-06-27 アクティブペプチド株式会社 Copd治療薬およびcopd治療用飲食品

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2395288A1 (fr) 1977-06-23 1979-01-19 Ppn Nouvelles compositions therapeutiques destinees notamment a la prevention et au traitement des maladies de plethore
US4557927A (en) 1983-03-10 1985-12-10 Kabushiki Kaisha Hoyashibara Food products and process for producing same
FR2543550B1 (fr) 1983-04-01 1985-08-09 Cortial Nouveaux derives de la tetrahydroxy-3', 4',5,7 flavone, leur methode de preparation et leur emploi therapeutique
JPS62201882A (ja) 1985-11-18 1987-09-05 Yamanouchi Pharmaceut Co Ltd イソフラボン誘導体
US4818558A (en) 1987-08-04 1989-04-04 Worthington Foods, Inc. Fiber/tofu food product and method for making the same
JPH0714927B2 (ja) 1988-04-06 1995-02-22 キッコーマン株式会社 イソフラボン化合物の製造法
FR2684301B1 (fr) * 1991-12-02 1995-03-24 Synthelabo Composition pharmaceutique contenant de l'egf pour le traitement des pathologies bronchopulmonaires.
US5223285A (en) * 1992-03-31 1993-06-29 Abbott Laboratories Nutritional product for pulmonary patients
JPH07506822A (ja) 1992-05-19 1995-07-27 ノボゲン リサーチ ピーティーワイ リミッテッド フィト−エストロゲン,類似体またはその代謝産物を含有する健康補助剤
DK171752B1 (da) 1992-07-06 1997-05-12 Birgitte Stilling Brødlignende produkt med blodsukkersænkende virkning til diabetikere samt pulverformig blanding til anvendelse ved fremstilling deraf
CA2160371A1 (en) 1993-04-16 1994-10-27 The Trustees Of Tufts College Method for treatment of menopausal and premenstrual symptoms
US5320949A (en) 1993-10-12 1994-06-14 Protein Technologies International, Inc. Process for producing aglucone isoflavone enriched vegetable protein fiber
WO1995010530A1 (en) 1993-10-12 1995-04-20 Protein Technologies International, Inc. An aglucone isoflavone enriched vegetable protein extract and isolate and process for producing
RU2151775C1 (ru) 1993-10-12 2000-06-27 Протеин Текнолоджиз Интернэшнл, Инк. Способ получения концентрата белка, способ извлечения изофлавона в концентрат белка, концентрат белка (варианты)
KR100303909B1 (ko) 1993-10-12 2001-11-30 캐더린 엘. 해리스 아글루콘 이소플라본이 농후한 식물성 단백질 훼이,훼이단백질및이의생산방법
US6140469A (en) 1993-10-12 2000-10-31 Protein Technologies International, Inc. Protein isolate having an increased level of isoflavone compounds and process for producing the same
US5589182A (en) 1993-12-06 1996-12-31 Tashiro; Renki Compositions and method of treating cardio-, cerebro-vascular and alzheimer's diseases and depression
US5463283A (en) 1994-05-24 1995-10-31 Bkl, Inc. Drive circuit for electroluminescent lamp
WO1996010341A1 (en) 1994-10-03 1996-04-11 Schouten Industries B.V. Food and health products
US5516528A (en) 1995-01-13 1996-05-14 Wake Forest University Dietary phytoestrogen in estrogen replacement therapy
IL115110A (en) 1995-08-30 1997-08-14 Chajuss Daniel Soy molasses
CA2192725C (en) * 1995-12-28 2004-04-20 Kenji Tsujihara Camptothecin derivatives
HUP9902145A3 (en) * 1996-02-29 2000-04-28 Nutri Pharma As Composition and its use as a food supplement or for lowering lipids in serum
US5702752A (en) 1996-03-13 1997-12-30 Archer Daniels Midland Company Production of isoflavone enriched fractions from soy protein extracts
CN1226805A (zh) * 1996-04-09 1999-08-25 纳幕尔杜邦公司 新型富含异黄酮的大豆蛋白产品及其生产方法
WO1998003084A1 (en) 1996-07-18 1998-01-29 Nutricor, Inc. Nutritious food preparations and methods for making them
US5654011A (en) 1996-07-30 1997-08-05 Energetics, Inc. Dietary supplements
US5726034A (en) 1996-09-06 1998-03-10 Protein Technologies International, Inc. Aglucone isoflavone enriched vegetable protein extract and protein material, and high genistein and daidzein content materials and process for producing the same
AU3218697A (en) 1997-01-21 1998-08-07 Minnesota Mining And Manufacturing Company Tubing for an ink delivery system
WO1998035699A1 (en) * 1997-02-12 1998-08-20 Nutri Pharma Asa Use of a combination of an anti-smoking composition and a dietary composition in smoking cessation
US5948814A (en) * 1997-02-20 1999-09-07 The Curators Of The University Of Missouri Genistein for the treatment of cystic fibrosis
ES2206821T3 (es) 1997-06-23 2004-05-16 Societe Des Produits Nestle S.A. Uso de una composicion nutritiva para la preparacion de una composicion liquida para diabeticos.
US5855892A (en) * 1997-09-19 1999-01-05 Potter; Susan M. Method for decreasing LDL-cholesterol concentration and increasing HDL-cholesterol concentration in the blood to reduce the risk of atherosclerosis and vascular disease

Also Published As

Publication number Publication date
HK1041634A1 (zh) 2002-07-19
JP2002530346A (ja) 2002-09-17
US6509043B1 (en) 2003-01-21
WO2000030664A1 (en) 2000-06-02
CA2352338A1 (en) 2000-06-02
DE69908809D1 (de) 2003-07-17
AU1404600A (en) 2000-06-13
EP1133307A1 (de) 2001-09-19
BR9915689A (pt) 2002-10-08
EP1133307B1 (de) 2003-06-11

Similar Documents

Publication Publication Date Title
DE69908809D1 (de) Verwendung einer zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen zur vorbeugung und/oder behandlung von lungenerkrankungen
DE69914947D1 (de) Zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen sowie ihre verwendung zur vorbeugung und/oder behandlung von typ ii diabetes, des metabolischen syndroms und assozierten kardiovaskulären erkrankungen
ATE253925T1 (de) Zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen sowie ihre verwendung zur vorbeugung und/oder behandlung von kardiovaskulären erkrankungen
DE60220145D1 (de) Verwendung eines mutterkrautextrakts zur regulierung der hautalterung
DE69827001D1 (de) Gewebedezellularization
ATE233558T1 (de) Verwendung von strontiumsälze zur behandlung von arthrose
DE69233250D1 (de) Kombinationen aus calzium und vitamin d
ES2152072T3 (es) Compuesto nutritivo mejorado resultado de la maceracion de maiz y su procedimiento de obtencion.
MX9306960A (es) Composiciones de extracto de corteza de roble, compositiones sinteticasrelacionadas, y metodo para su utilizacion.
DE59509848D1 (de) Kombinationspräparat zur anwendung bei immunologischen erkrankungen
DE69734405D1 (de) Verwendung von CS-866 (Olmersartan) zur Herstellung eines Medikaments für die Behandlung von Arteriosklerose
DE69713300D1 (de) Benzopyran derivate mit leukotrien-antagonistischer wirkung
DE69635305D1 (de) Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma
ATE61524T1 (de) Verwendung von hyperoxygenierten oelen zur herstellung eines arzneimittells zur behandlung von herpes.
NO992066L (no) Piperazinoderivater som neurokininantagonister
ES2110550T3 (es) Tratamiento de la carne o del pescado.
ATE149832T1 (de) Verwendung von cromakalim/brl 38227 zur behandlung der überreaktivität der luftwege
ZA858672B (en) New use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins
DE60317178D1 (de) Verwendung einer wässrigen Lösung mit einem oder mehreren Bifluoriden zur Verbesserung des Trocknungsprozesses von Frischholz
ATE216842T1 (de) Hypoallergenischer instantbrei und verfahren zur herstellung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties